|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-2-21
|
|
pubmed:abstractText |
Primary hyperparathyroidism (pHPT)-related hypercalcemia is considered to represent a risk factor for the development of pancreatitis. We therefore explored whether mutations in genes that were previously identified to increase the risk for pancreatitis coexist in a cohort of 826 patients with pHPT prospectively studied between 1987 and 2002.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
368-74
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18076731-Carrier Proteins,
pubmed-meshheading:18076731-Cystic Fibrosis Transmembrane Conductance Regulator,
pubmed-meshheading:18076731-Female,
pubmed-meshheading:18076731-Humans,
pubmed-meshheading:18076731-Hyperparathyroidism, Primary,
pubmed-meshheading:18076731-Male,
pubmed-meshheading:18076731-Middle Aged,
pubmed-meshheading:18076731-Mutation,
pubmed-meshheading:18076731-Pancreatitis,
pubmed-meshheading:18076731-Risk Factors,
pubmed-meshheading:18076731-Trypsin,
pubmed-meshheading:18076731-Trypsinogen
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
|
|
pubmed:affiliation |
Department of Medicine I, St. Josef-Hospital, Ruhr-University, Medical School, Bochum, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
